Similarly, when we assessed GPR133 expression as a function of ATRX status, there was no difference within the core of IDH mutant gliomas with preserved (oligodendrogliomas) or lost (astrocytomas) ATRX (Figure 4Ci). This evidence concerns the gene IDH2 and oligodendroglioma.